Berman Capital Advisors LLC acquired a new position in shares of CME Group Inc (NASDAQ:CME) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 276 shares of the financial services provider’s stock, valued at approximately $51,000.
Several other hedge funds have also recently added to or reduced their stakes in the company. Resources Investment Advisors Inc. boosted its position in CME Group by 2,800.0% during the 4th quarter. Resources Investment Advisors Inc. now owns 145 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 140 shares during the period. Ruggie Capital Group purchased a new stake in CME Group during the 4th quarter worth $28,000. Smith Asset Management Group LP boosted its position in CME Group by 200.0% during the 4th quarter. Smith Asset Management Group LP now owns 150 shares of the financial services provider’s stock worth $28,000 after purchasing an additional 100 shares during the period. Nelson Roberts Investment Advisors LLC purchased a new stake in CME Group during the 4th quarter worth $33,000. Finally, Athena Capital Advisors LLC purchased a new stake in CME Group during the 4th quarter worth $43,000. Institutional investors and hedge funds own 86.63% of the company’s stock.
Get CME Group alerts:CME has been the subject of a number of research reports. Berenberg Bank raised shares of CME Group from a “hold” rating to a “buy” rating and set a $220.00 price target for the company in a research report on Tuesday, November 20th. BidaskClub cut shares of CME Group from a “hold” rating to a “sell” rating in a research report on Wednesday, February 20th. Bank of America reaffirmed a “neutral” rating and set a $191.00 price target (down from $200.00) on shares of CME Group in a research report on Friday, January 11th. They noted that the move was a valuation call. Atlantic Securities initiated coverage on shares of CME Group in a research report on Wednesday, November 28th. They set a “neutral” rating and a $200.00 price target for the company. Finally, Barclays initiated coverage on shares of CME Group in a research report on Tuesday, December 4th. They set an “overweight” rating and a $210.00 price target for the company. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $193.47.
In other news, Director Jeffrey M. Bernacchi sold 10,087 shares of the stock in a transaction dated Tuesday, February 26th. The shares were sold at an average price of $177.94, for a total transaction of $1,794,880.78. Following the transaction, the director now owns 42,004 shares of the company’s stock, valued at $7,474,191.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO John W. Pietrowicz sold 17,960 shares of the stock in a transaction dated Wednesday, January 2nd. The stock was sold at an average price of $186.92, for a total transaction of $3,357,083.20. Following the transaction, the chief financial officer now directly owns 44,780 shares in the company, valued at approximately $8,370,277.60. The disclosure for this sale can be found here. Insiders have sold 32,609 shares of company stock worth $5,984,391 in the last ninety days. Corporate insiders own 0.43% of the company’s stock.
NASDAQ:CME opened at $170.37 on Wednesday. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.01 and a quick ratio of 1.09. The stock has a market capitalization of $61.12 billion, a price-to-earnings ratio of 24.98, a PEG ratio of 2.25 and a beta of 0.30. CME Group Inc has a 1-year low of $153.90 and a 1-year high of $197.08.
CME Group (NASDAQ:CME) last issued its quarterly earnings results on Thursday, February 14th. The financial services provider reported $1.77 EPS for the quarter, topping the consensus estimate of $1.75 by $0.02. CME Group had a net margin of 45.53% and a return on equity of 9.85%. The business had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.22 billion. During the same quarter last year, the company posted $1.12 earnings per share. The company’s quarterly revenue was up 37.4% compared to the same quarter last year. As a group, sell-side analysts expect that CME Group Inc will post 7.07 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, March 25th. Stockholders of record on Friday, March 8th will be given a dividend of $0.75 per share. This is a boost from CME Group’s previous quarterly dividend of $0.70. The ex-dividend date of this dividend is Thursday, March 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.76%. CME Group’s dividend payout ratio (DPR) is presently 41.06%.
ILLEGAL ACTIVITY NOTICE: This report was first reported by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.tickerreport.com/banking-finance/4217206/berman-capital-advisors-llc-invests-51000-in-cme-group-inc-cme.html.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Recommended Story: What are trading strategies for the 52-week high/low?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
No comments:
Post a Comment